Pathological Gambling Clinical Trial
Official title:
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Pathological gambling (PG) is characterized by a persistent pattern of continued gambling behavior despite its adverse consequences. PG is a chronic, progressive, male-dominated disorder, which has a prevalence of 1% to 3.4% among US adults. Deep transcranial magnetic stimulation (TMS) is a novel neuro-stimulation method capable of inhibiting neuronal activity when given in low frequency. The hypothesis of this study is that , Pathological gambling will be ameliorated if low frequency magnetic field using Brainsway H1 coil will be applied to the left dorso-lateral prefrontal cortex of these patients.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | June 2012 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Pathological gambling according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) Exclusion Criteria: - History of a primary major psychiatric or cognitive disorder according to DSM IV apart from Pathological gambling. - Current alcohol or other substance abuse or dependence. - Alcohol or other substance abuse or dependence during the last 12 months before recruitment. - History of or evidence of significant brain malformation or neoplasm, head injury, cerebral vascular events, neurodegenerative disorder affecting the brain or prior brain surgery. - Significant neurological co-morbidity. - psychiatric co-morbidity. - psychotropic medications. - Severe somatic co morbidity. - Cardiac pace makers, other electronic implants, intracranial metallic particles. - History of seizures or epileptiform activity. - Pregnancy and lactation. - Patients who cannot communicate reliably with the investigator or who are not likely to cope with the requirements of the experiment. - Patients unwilling or unable to give written informed consent. - Patients with a high risk for severe violence or suicidality as assessed during the screening interview. - Participation in a clinical trial within the last 30 days before the beginning of this clinical trial or similar participation in another clinical trial. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Israel | Beer Yaakov Mental Health Center | Beer Yaakov | Hashfela |
Lead Sponsor | Collaborator |
---|---|
BeerYaakov Mental Health Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SOGS (South Oaks Gambling Screen) | The South Oaks Gambling Screen is a 20-item questionnaire based on Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) criteria for pathological gambling. | 45 days | No |
Primary | Dannon Ainhold Gambling Scale | A scale for assessment of pathological gambling | 45 days | No |
Primary | visual analogue scale | An instrument for assessment of desire to indulge in gambling | 45 Days | No |
Secondary | Hamilton Depression 24 items | Depression assessment scale | 45 Days | No |
Secondary | Hamilton Anxiety scale | Anxiety assessment scale | 45 days | No |
Secondary | Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | A scale for assessment of compulsions and obsessions | 45 days | No |
Secondary | Clinical Global Impression Improvement (CGI-I) | A scale for assessment of global clinical improvement | 45 days | No |
Secondary | Social Adaptational Scale(SAS) | A scale for assessment of Social Adaptation | 45 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Completed |
NCT01843699 -
Topiramate Trial for Pathological Gamblers
|
Phase 2 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 |